Security record · archived quarter
COGT
Cogent Biosciences, Inc. · Healthcare · Biotechnology
13Tracked holders
0Δ holders
17.19MShares held
$134.06MReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -26.9% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 104 | +4 | 108.47M | $4.20B | +7 | −3 |
| Q1 2026 | 103 | +9 | 108.14M | $4.02B | +15 | −6 |
| Q4 2025 | 92 | +1 | 96.22M | $3.42B | +1 | — |
| Q3 2025 | 20 | +4 | 59.75M | $857.99M | +4 | — |
| Q2 2025 | 13 | -2 | 45.58M | $327.23M | — | −2 |
| Q1 2025 | 12 | -1 | 13.98M | $83.77M | — | −1 |
| Q4 2024 | 13 | 0 | 17.19M | $134.06M | +1 | −1 |
| Q3 2024 | 12 | +2 | 19.61M | $211.75M | +2 | — |
| Q2 2024 | 10 | — | 18.90M | $159.29M | — | — |
Who holds it · Q4 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 5.35M | -48.9% | $41.71M | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 2 | Adage Capital Partners ✦ | 4.30M | +5.8% | $33.54M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 3 | State Street Global Advisors ✦ (passive) | 3.92M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 2.31M | +1.2% | $18.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 2.31M | +1.2% | $18.01M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 339.99K | -25.6% | $2.65M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 339.99K | -25.6% | $2.65M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 284.85K | -16.8% | $2.22M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 284.85K | -16.8% | $2.22M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 242.93K | New | $1.89M | 0.0% | New | 1 | SEC ↗ |
| 11 | Fisher Asset Management ✦ | 110.91K | -14.3% | $865,082 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 101.99K | -4.3% | $795,522 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 97.66K | +912.4% | $761,771 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 97.66K | +912.4% | $761,771 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Millennium Management ✦ | 56.51K | -96.5% | $440,794 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 49.64K | +12.4% | $388,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 27.59K | +135.6% | $215,225 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 27.59K | +135.6% | $215,225 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Renaissance Technologies | $1.89M | 0.0% |
Exited
| Marshall Wace | $798,174 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 304 holders, 186.07M shares, $6.90B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q4 2024 ·
Methodology ·
Get this via the API